Atricure Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Atricure Inc in the second quarter 2026?
Atricure Inc achieved a return on average equity (ROE) of 2.14 % in its second quarter 2026, this is above ATRC's average return on equity of -14.04%.
Atricure Inc shareholder's equity over the 12 months ending in its second quarter 2026 are valued at $494 million

ROE has advanced compared to -0.95% in the first quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 59 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 2303 to 2337.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	11.18 %	8.15 %	6.72 %	2.47 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	11	-5	-11	-29	-36
Return On Equity (TTM)	2.14 %	-0.95 %	-2.43 %	-6.2 %	-7.88 %
ATRC's Total Ranking	# 2337	# 2303	# 1150	# 2225	# 0
Equity (TTM) in Millions	516	492	492	477	464
Seq. Equity Change	5.03 %	-0.05 %	3.24 %	2.59 %	2.17 %
Seq. Net Income Change	8191.67 %	-93.85 %	-	-	-

Back to ATRC Management Effectiveness >> ATRC's 5 Years Annual ROE >> Compare ATRC ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 60
Sector	# 181
Overall	# 2337

Return On Equity Statistics
High	Average	Low
11.48 %	-14.04 %	-54.15 %
(Dec 31 2021)		(Dec 31 2012)

ATRC Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	492	461	466	457	484
Y / Y Equity Change	6.72 %	-1.12 %	2.06 %	-5.58 %	17.3 %
Net Income in Millions	-11	-45	-30	-46	50
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-2.33 %	-9.7 %	-6.53 %	-10.17 %	10.38 %

Back to ATRC Management Effectiveness >> ATRC's 5 Years Annual ROE >> Compare ATRC ROE to its Competitors

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ATRC's' Return on Equity at Yahoo Finance
ATRC's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ATRC's Competitors
Subscribers only: Roe for Atricure Inc 's Suppliers
Subscribers only: Return On Equity for ATRC's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector	ROE
National Vision Holdings Inc	5.71 %
Conmed Corporation	5.51 %
Pfizer Inc	4.91 %
Privia Health Group Inc	4.23 %
Becton Dickinson And Company	3.79 %
Alkermes Plc	3.72 %
Lifemd Inc	3.47 %
Lifestance Health Group Inc	3.39 %
Revvity Inc	3.27 %
Bio rad Laboratories Inc	3.15 %
Envista Holdings Corporation	3.08 %
Immucell Corporation	2.68 %
Surgery Partners Inc	2.63 %
Mimedx Group Inc	2.61 %
Cormedix Inc	2.18 %
Atricure Inc	2.14 %
Pacira Biosciences inc	2.13 %
Warby Parker Inc	2.06 %
Repligen Corp	1.98 %
Arvinas Inc	1.91 %
Waters Corporation	1.88 %
Omada Health Inc	1.84 %
Radnet Inc	1.42 %
Icu Medical Inc	1.41 %
Biomarin Pharmaceutical Inc	1.18 %
Staar Surgical Co	1.08 %
Champions Oncology Inc	0.94 %
Delcath Systems Inc	0.46 %

Date modified: 2026-09-26T07:10:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.